MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine"

  • 2026 International Congress

    Dopaminergic Modulation Of Contextual Emotional Appraisal And Shame In Parkinson’s Disease

    S. Catalano Chiuve, D. Benis, C. Rime, M. Maradan-Gachet, J. Potheegadoo, F. Bernasconi, O. Blanke, P. Krack, V. Fleury (Geneva, Switzerland)

    Objective: To investigate the influence of dopaminergic replacement therapy (DRT) on emotional appraisal and shame-related responses in PD patients with fluctuations. Background: Shame and embarrassment…
  • 2026 International Congress

    Dopamine depletion does not mitigate striatal reward prediction error signals

    JH. Shin, JS. Kim, HK. Chung, MW. Jung (Seoul, Republic of Korea)

    Objective: To elucidate the role of dopamine in computing reward prediction error signals in the basal ganglia Background: Phasic discharges of midbrain dopamine neurons are…
  • 2026 International Congress

    R1 from 18PR04.MZ as a Proxy for Cerebral Blood Flow in Degenerative Parkinsonism: Comparison with 15O-H2O PET/CT.

    A. Damian, I. Amorin, V. Kramer, J. Higgie, I. Cordero, L. Gutierrez, E. Savio, T. Arias, O. Alonso, R. Ferrando (Montevideo, Uruguay)

    Objective: To evaluate the relationship between R1 from 18PR04.MZ and CBF assessed by 15O-H2O PET/CT in patients with parkinsonian syndromes. Background: 18PR04.MZ is an effective…
  • 2025 International Congress

    Mathematical and Computational Modeling Prototype to Understand the Evolution of Parkinson’s disease using Four Differential Equations

    G. Sa, A. Rodrigues Tavares, M. Silva Bissaco (Mogi das Cruzes, Brazil)

    Objective: Apply four differential equations to generate projections considering the effect of dopamine on Parkinson’s disease progression, leading to the development of an initial prototype…
  • 2025 International Congress

    Detection and classification of Parkinson’s disease from neuroimaging modalities using machine learning and artificial intelligence: a systematic review

    F. Ebrahimian Sadabad, P. Honhar, S. Houshi, F. Nejati, S. Bagherieh, A. Brackett, F. Yazdanpanah, S. Cayir, M. Hosseini, H. Tagare, D. Matuskey (New Haven, USA)

    Objective: This systematic review evaluates performance of machine learning (ML) and artificial intelligence (AI) techniques applied to neuroimaging modalities in differentiating Parkinson’s disease (PD) patients…
  • 2025 International Congress

    Dopaminometer: A Smartphone-Based Application to Predict Striatal Dopaminergic Deficit in Prodromal and Manifest Parkinson’s disease

    K. Gunter, K. Groenewald, J. Klein, T. Aubourg, J. Razzaque, C. Lo, P. Ratti, L. van Hillegondsberg, J. Welch, A. Nastasa, K. Bradley, D. Mcgowan, B. Orso, P. Mattioli, M. Pardini, S. Raffa, F. Massa, D. Arnaldi, S. Arora, M. Hu (Oxford, United Kingdom)

    Objective: To assess the feasibility of a smartphone-based application (“Dopaminometer”) for predicting abnormal vs. normal dopamine transporter (DaT) scans and dopaminergic ratios in individuals with…
  • 2025 International Congress

    Functional Segregation in Parkinson’s Disease

    DN. Su, J. Hanania, A. Pavel, M. Matarazzo, J. Mckenzie, J. Cheng, N. Vafai, S. Dhaliwal, V. Sossi, A. Stoessl (Beijing, China)

    Objective: We assessed patterns of dopamine (DA) release and striatal activation induced by behavioural tasks involving corticostriatal loops in Parkinson’s disease (PD) and healthy control…
  • 2025 International Congress

    Artificial Intelligence in the Early Detection of Parkinson’s Disease: Advances, Challenges, and Future Perspectives

    ME. Mellaci (SÃO PAULO, Brazil)

    Objective: This study reviews AI’s role in early PD detection, comparing AI-driven diagnostic methods with conventional clinical approaches in accuracy, reliability, and applicability. Background: Parkinson’s…
  • 2025 International Congress

    The role of serotonergic mechanisms in the formation of levodopa-induced drug-induced dyskinesias in Parkinson’s disease

    D. Pulatova, F. Saidvaliev (Tashkent, Uzbekistan)

    Objective: To study the quantitative content of serotonin and dopamine in the blood plasma of patients with Parkinson's disease and to conduct a clinical and…
  • 2025 International Congress

    Long-Term Effect of Dopaminergic Treatment on gait in De Novo Parkinson’s Disease: the DNA mobile health technology longitudinal study

    A. Pilotto, C. Zatti, A. Rizzardi, C. Hansen, J. Gerritz, R. Romijnders, M. Catania, A. Lupini, W. Maetzler, A. Padovani (Brescia, Italy)

    Objective: to evaluate the long-term effect of dopaminergic treatment on gait in Parkinson’s disease Background: monitoring the progression of Parkinson's disease (PD) and response to…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 27
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley